Heritable sclerosing bone disorders: presentation and new molecular mechanisms

Area of Science:

• Bone biology
• Genetics
• Cellular pathways

Background:

• Sclerosing bone disorders present diverse clinical features and cellular origins.
• Osteoclast-rich osteopetrosis links to osteoclast function gene mutations.
• Osteoclast-poor osteopetrosis and other sclerotic conditions involve factors regulating osteoclast differentiation.

Purpose of the Study:

• To categorize sclerosing bone disorders based on affected cell types and molecular pathways.
• To review genetic underpinnings of various osteosclerotic conditions.
• To discuss clinical implications and insights into bone biology.

Main Methods:

• Literature review and synthesis of genetic and clinical data on sclerosing bone disorders.
• Classification of disorders based on affected cell lineages (osteoclasts, osteoblasts) and signaling pathways.
• Analysis of gene mutations associated with specific sclerotic phenotypes.

Main Results:

• Disorders are grouped by osteoclast dysfunction (e.g., osteopetrosis), osteoblast regulation (e.g., Wnt pathway mutations causing hyperostosis, sclerosteosis), or transforming growth factor-beta signaling (Camurati-Engelman disease, osteopoikilosis).
• Eicosanoid pathway gene mutations are linked to Ghosal syndrome and pachydermoperiostosis.
• Genetic defects in osteoclast differentiation factors contribute to osteoclast-poor osteopetrosis.

Conclusions:

• Genetic mutations in distinct cellular pathways (osteoclast function/differentiation, TGF-β, Wnt, eicosanoid) underlie diverse sclerosing bone disorders.
• Understanding these genetic bases enhances knowledge of bone biology and osteoblast/osteoclast regulation.
• This classification aids in diagnosing and potentially treating these rare skeletal conditions.